Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Covis Group Completes Acquisition of AMAG Pharmaceuticals
2 Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
3 Covis Group Announces Data for Ciraparantag Published in Blood, the Journal of the American Society of Hematology
4 Apollo to buy specialty pharmaceutical company Covis Pharma
5 Covis Pharma BV Initiates Phase 3 Clinical Trial of Alvesco (Ciclesonide) Inhaler for the Treatment of COVID-19
6 Catalepsy Treatment Market 2020 Strategies and Insight Driven Transformation || Top Players – Teva Pharmaceutical Industries Ltd., Upsher-Smith Laboratories, LLC, Piramal Critical Care, Vintage Labs
7 Leaders In Life Sciences Key Takeaways
8 Funds Managed by Affiliates of Apollo Global Management to Acquire Covis Pharma From Cerberus
9 Rajiv De Silva Joins Covis Pharma as Chairman of the Board of Directors
10 Covis Pharma
11 Apollo Nears Deal to Buy Covis Pharma From Cerberus
12 Tag: Inotropic Agents Market Growth
13 Other news to note for Nov. 16, 2020 | 2020-11-16
14 Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
15 Amyotrophic Lateral Sclerosis (ALS) Market Overview, Industry Top Manufactures,
16 AMAG Pharma up 41% on takeover rumor
17 Covis Group to Acquire AMAG Pharmaceuticals in $647 Million Deal
18 Covis Group S.à rl Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.
19 Covis Pharma's Alvesco (ciclesonide) Now Available at Walgreens For Reduced Cost
20 Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Overview, Opportunities,
21 Amyotrophic Lateral Sclerosis Therapeutics Market 2020 Analysis Research and Development Forecast by 2026
22 Covis Pharma studies asthma drug Alvesco for Covid-19
23 MVP: Dechert's Mark Thierfelder
24 Apollo moves on Covis Pharma in $700M+ deal
25 Apollo Global Management's Acquisition of Covis Pharma
26 Hydroxychloroquine (Plaquenil) Market Insights and Global Outlook During 2020 to 2026 Along With Covid-19 Impa
27 Trending now: Covid-19 impact on Amyotrophic Lateral Sclerosis Therapeutics Market Segmentation, Analysis by Recent Trends, Development & Growth by Regions | Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex
28 Amag buyers bet big on reversal agent
29 Amyotrophic Lateral Sclerosis (ALS) Market – Trends & Leading Players| Industry Size, Growth, Segments, Revenue, Manufacturers & Forecast Research Report | Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex
30 Amyotrophic Lateral Sclerosis (ALS) Treatment Market overview; key trends, market size, and key factors defining the Industry forecast to 2025
31 AMAG tops its year-long, activist driven transformation with a $647M selloff to private equity
32 Amyotrophic Lateral Sclerosis (ALS) Market, Epidemiology Insights, Size, Share, Segmentation, Trends, and Forecast To 2026
33 Alpha-Adrenoreceptor Antagonists Market with Industry Capacity, Future Prospects, Economic Aspect and Forecast to 2027- Sanofi, Pro Doc, Aspri Pharma, Etc.
34 Apollo buys drugmaker Covis from Cerberus
35 Capital One Closes $350MM Senior Credit Facility for Covis Pharma
36 CGTN: Shanghais Pudong to be pioneer in Chinas new reform drive
37 AstraZeneca Unloads Three Asthma and Rhinitis Drugs to Covis Pharma for $350 Million
38 Nasal Polyposis Drugs Market || Leading Players – Covis Pharma, Regeneron Pharmaceuticals., F. Hoffmann-La Roche Ltd., Pfizer Inc
39 Bullion Market closing rates
40 DIPAM signs agreement with World Bank for advisory services on Asset Monetization
41 Cerberus Is Said to Weigh Sale of $800 Million Drugmaker Covis
42 Bitmain Releases Rack-Style New Miner, Bringing Next Level Computing Power
43 AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients
44 Colt DCS launches its largest data centre in Japan, Inzai 3
45 Private equity pushes into healthcare: 13 latest deals
46 Sensex up 85.81 pts
47 AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
48 Punjab National Bank Q2 FY-21 Financial Results: Festive season to lift economic spirits: PNB MD & CEO
49 Lattu Kids raises seed funding from Mumbai Angels Network
50 HSIL invests ₹100 cr for plastic pipes plant expansion in Telangana
51 Williamsburg doctor is recruiting locals with coronavirus to try experimental treatment
52 Covis Pharma to Acquire US Rights from GlaxoSmithKline for Fortaz®, Zinacef®, Lanoxin®, Parnate®, and Zantac® Injection
53 Concordia Healthcare Corp. Announces Completion of Acquisition of Covis Pharma Commercial Assets for US$1.2 Billion
54 Cerberus said to mull $800m Covis Pharma sale
55 Concordia Healthcare to Buy Some Assets of Covis Pharma
56 Covis Pharma to Acquire US Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
57 The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
58 SELB Down But Not Out, PFE Takes 9.9% Stake In CStone, ZSAN Plunges, AMAG On The Block?
59 Other news to note for Nov. 19, 2020 | 2020-11-19
60 Just days after buyout notice, AMAG faces FDA push to withdraw premature-birth med Makena
61 Coronavirus: You might be eligible for this paid study
62 AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik
63 AstraZeneca Closes Sale Of Alvesco, Omnaris And Zetonna Rights To Covis Pharma
64 FDA urges removal of Amag drug from market amid $500M acquisition
65 Covis Pharma Holdings Sarl Appoints Dean J. Mitchell As Executive Chairman of the Board
66 Bed Bath & Beyond, Boeing rise; Marathon, Allstate fall
67 Pharma Co. Hid Value To Shrink Payout, Says Former Exec
68 After-Hours Stock Movers 09/30: (AMAG) (SAIL) (PLTR) Higher; (ZSAN) (LOGC) (SPI) Lower (more...)
69 Sunovion Divests US Market Rights to Asthma, Allergic Rhinitis Therapies
70 Phase 3 Trial Assessing Ciclesonide Inhalation Aerosol for COVID-19 Underway
71 Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board
72 HPS to Lend $1 Billion for Health Care M&A in Private Debt Push
73 AstraZeneca offloads more Seroquel rights, this time to Cheplapharm for $42M
74 AMAG Pharmaceuticals Provides COVID-19 Company Update Nasdaq:AMAG
75 AstraZeneca sells 3 drugs for $350M upfront
76 Global Hydroxychloroquine Market is Expected to Grow at a CAGR of 33.47% during the forecast period
77 Former Milberg, Morgan & Morgan Litigator Joins Cannabis Company (1)
78 Coronavirus tracker: Sinovac unveils midstage vaccine data; Daewoong OK'd to test tapeworm med against virus
79 UB researchers launch study to learn if an asthma treatment can ease Covid-19
80 Pre-Open Stock Movers 10/01: (AEL) (AMAG) (BBBY) Higher; (ZSAN) (LOGC) (SPI) Lower (more...)
81 Releases New Research Report on Hydroxychloroquine (Plaquenil) Market 2020-2025 | International Company's
82 Bausch Health to acquire ophthalmology assets of Allegro
83 Global Hydroxychloroquine Market to Surpass US$ 6,781.1 Million by 2027, Corona virus (COVID-19) outbreak to propel Market growth
84 US awards $450m contract to Regeneron for Covid-19 therapy supply
85 Takeda bets on Engitix and its drug discovery platform for liver fibrosis
86 Cerebellar Agenesis treatment Industry Analysis, COVID 19 Trends, Outlook, and Opportunity Analysis Up to 2026
88 AbbVie signs immunotherapy deal with I-Mab worth $2bn
89 InventisBio secures $147m in Series D funding round
90 Q&A: Breaking new ground in pharma packaging with Honeywell
91 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Share, Price, Trend And Forecast 2026|Top Players: Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma
92 Gilead and Jounce sign cancer immunotherapy deal valued at $805m
93 Why the world’s toughest activist hedge fund is after SoftBank
94 Destiny Pharma and SporeGen to develop preventive Covid-19 therapy
95 tech trends: COVID-19 leads Twitter mentions in May 2020
96 Amyotrophic Lateral Sclerosis (ALS) Treatment Market is Booming Worldwide By Top Key Players: Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment
97 Risk of Severe Covid-19 Is Minimal in School-Age Children
98 Janssen gets FDA approval for Spravato spray for depressive symptoms
99 Sanofi licenses non-core drugs to Covis
100 J&J's Covid-19 vaccine prevents severe disease in preclinical tests